BCYC Q4 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-15.5% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$32M-1011.3% margin

Net Income

-$30M-941.2% margin

EPS (Diluted)

$-1.01

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$411M

Total Liabilities

$140M

Stockholders' Equity

$271M

Cash & Equivalents

$339M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-15.5%
Gross Profit	$3M	$4M	-15.5%
Operating Income	-$32M	-$18M	-78.7%
Net Income	-$30M	-$18M	-66.2%